dwigshafen RIsk and Cardiovascular health Study

• Conditions: I00-I02; I05-I09; I10-I15; I20-I25; I26-I28; I30-I52; I60-I69; I70-I79; Acute rheumatic fever; Chronic rheumatic heart diseases

• Registration Number: DRKS00032641
• Lead Sponsor: RIC Study LLC

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-10-10
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 3316

Inclusion Criteria

Indication for Coronary Angiography

Exclusion Criteria

Malignancy

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cardiovascular death (obtained from death certificates, local person registries, 10 years after study start)

Secondary Outcome Measures

Name	Time	Method
All-cause mortality; coronary artery disease (obtained from death certificates, local person registries, 10 years after study start)